JAM-1 is a ligand of the β2 integrin LFA-1 involved in transendothelial migration of leukocytes

G Ostermann, KSC Weber, A Zernecke, A Schröder… - Nature …, 2002 - nature.com
G Ostermann, KSC Weber, A Zernecke, A Schröder, C Weber
Nature immunology, 2002nature.com
Inflammatory recruitment of leukocytes is governed by dynamic interactions between
integrins and endothelial immunoglobulin superfamily (IgSF) proteins. We have identified
the IgSF member junctional adhesion molecule 1 (JAM-1) as a ligand of the β2 integrin
lymphocyte function–associated antigen 1 (LFA-1). Under static and physiological flow
conditions, JAM-1 contributed to LFA-1–dependent transendothelial migration of T cells and
neutrophils as well as LFA-1–mediated arrest of T cells. The latter was triggered by …
Abstract
Inflammatory recruitment of leukocytes is governed by dynamic interactions between integrins and endothelial immunoglobulin superfamily (IgSF) proteins. We have identified the IgSF member junctional adhesion molecule 1 (JAM-1) as a ligand of the β2 integrin lymphocyte function–associated antigen 1 (LFA-1). Under static and physiological flow conditions, JAM-1 contributed to LFA-1–dependent transendothelial migration of T cells and neutrophils as well as LFA-1–mediated arrest of T cells. The latter was triggered by chemokines on endothelium that was stimulated with cytokines to redistribute JAM-1 from the tight junctions. Transfectants expressing JAM-1 supported LFA-1–mediated adhesion of leukocytes, which required the membrane-proximal Ig-like domain 2 of JAM-1. Thus, JAM-1 is a counter-receptor for LFA-1 that is ideally situated to guide and control transmigration during leukocyte recruitment.
nature.com